By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioLineRx Ltd. 

19 Hartum Street
P.O. Box 45158
Jerusalem 91450      Israel
Phone: 972-2-548-9100 Fax: 972-2-548-9101



Company News
BioLineRx Ltd. Announces Regulatory Submission For Phase 2b Trial For Novel AML Consolidation Treatment 3/2/2015 10:24:32 AM
BIOCEO15: BioLineRx Ltd. CEO Touts New Celiac Drug, Fleshes Out Novartis AG (NVS) Partnership Terms 2/10/2015 3:48:25 PM
BioLineRx Ltd. To Present At 2015 Biotechnology Industry Organization (BIO) CEO & Investor Conference In New York On February 10 2/3/2015 10:27:49 AM
BioLineRx Ltd. Announces Completion Of Enrollment In CE Mark Registration Trial Of BCM (BL-1040), A Novel Medical Device For Prevention Of Cardiac Remodeling Following Acute Myocardial Infarction 1/14/2015 9:34:49 AM
BioLineRx Ltd. Completes Dose Escalation Stage Of Phase 1 Trial For Novel Stem Cell Mobilization Treatment 1/6/2015 9:15:35 AM
BioLineRx Ltd. To Present At Biotech Showcase 2015 Conference In San Francisco 1/6/2015 8:39:42 AM
BioLineRx Ltd. Out-Licenses Novel Skin Lesion Treatment To Omega Pharma 12/24/2014 9:18:52 AM
BioLineRx Ltd. Presents Multi-Year Clinical Development Plan For Its BL-8040 Hematological Cancer Therapeutic Platform 12/12/2014 9:04:04 AM
BioLineRx Ltd. Reports Positive Data from Ongoing Phase 2a Study for AML Treatment at American Society of Hematology Conference 12/8/2014 10:52:11 AM
BioLineRx Ltd. Reports Third Quarter 2014 Financial Results 11/10/2014 10:12:57 AM